We are live on ! Find out more
EI

Ellevest Inc Portfolio holdings

AUM $719M
1-Year Est. Return 23.17%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+23.17%
3 Year Est. Return
+54.13%
5 Year Est. Return
+49.85%
10 Year Est. Return
AUM
$684M
AUM Growth
+$127M
Cap. Flow
+$55.4M
Cap. Flow %
8.1%
Top 10 Hldgs %
68.26%
Holding
1,457
New
246
Increased
593
Reduced
251
Closed
183

Sector Composition

Rank Sector Weight
1 Technology 3.61%
2 Communication Services 1.94%
3 Healthcare 1.7%
4 Consumer Discretionary 1.68%
5 Financials 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRUB
1151
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$1K ﹤0.01%
+5
New +$739
CLGX
1152
DELISTED
Corelogic, Inc.
CLGX
$1K ﹤0.01%
13
+4
+44% +$299
BMY.RT
1153
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1K ﹤0.01%
1,250
KNL
1154
DELISTED
Knoll, Inc.
KNL
$1K ﹤0.01%
+39
New +$526
STFC
1155
DELISTED
State Auto Financial Corp
STFC
$1K ﹤0.01%
+69
New +$1.05K
ACRS icon
1156
Aclaris Therapeutics
ACRS
$726M
-135
Closed
ADEA icon
1157
Adeia
ADEA
$2.94B
-737
Closed -$2K
ADT icon
1158
ADT
ADT
$5.58B
-65
Closed -$1K
AEP icon
1159
American Electric Power
AEP
$69.6B
$0 ﹤0.01%
1
AGNC icon
1160
AGNC Investment
AGNC
$12.4B
-3,065
Closed -$43K
AKBA icon
1161
Akebia Therapeutics
AKBA
$354M
$0 ﹤0.01%
173
+157
+981% +$458
ALC icon
1162
Alcon
ALC
$33.6B
-28
Closed -$2K
ALGT icon
1163
Allegiant Air
ALGT
$2.64B
-9
Closed -$1K
AMRX icon
1164
Amneal Pharmaceuticals
AMRX
$5.85B
$0 ﹤0.01%
+26
New +$115
ANGO icon
1165
AngioDynamics
ANGO
$611M
$0 ﹤0.01%
+25
New +$317
AOA icon
1166
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.19B
-25
Closed -$1K
ARAY icon
1167
Accuray
ARAY
$32M
$0 ﹤0.01%
64
+5
+8% +$18
ARCT icon
1168
Arcturus Therapeutics
ARCT
$164M
-30
Closed -$1K
ARMK icon
1169
Aramark
ARMK
$15B
-33
Closed -$1K
ASMB icon
1170
Assembly Biosciences
ASMB
$498M
-1
Closed
ATMP icon
1171
iPath Select MLP ETN
ATMP
$639M
-1,402
Closed -$13K
AXSM icon
1172
Axsome Therapeutics
AXSM
$11.2B
-1
Closed
BCRX icon
1173
BioCryst Pharmaceuticals
BCRX
$2.28B
$0 ﹤0.01%
3
-28
-90% -$144
BCS icon
1174
Barclays
BCS
$92.7B
-11,407
Closed -$57K
BGS icon
1175
B&G Foods
BGS
$287M
-73
Closed -$2K

Similar funds

Ellevest Inc's Q4 2020 Portfolio in Review

As of Q4 2020, Ellevest Inc held 1,457 positions worth $684M, up 23% from $557M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Ellevest Inc deployed $55.4M of net new capital in Q4 2020, opening 246 new positions and adding to 593 existing holdings. Its largest new stake was iShares Broad USD High Yield Corporate Bond ETF: 34,659 shares worth $1.43M.

By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 3.6% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was State Street Utilities Select Sector SPDR ETF, an estimated $1.07M trimmed.

  • Ellevest Inc's largest Q4 2020 buy was iShares Broad USD High Yield Corporate Bond ETF: 34,659 shares worth $1.43M.
  • Ellevest Inc added most to Vanguard Morningstar Total Stock Market ETF in Q4 2020, an estimated $11.3M increase.
  • Ellevest Inc's biggest Q4 2020 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $1.07M.
  • Ellevest Inc fully exited Edwards Lifesciences in Q4 2020, selling an estimated $797K.
  • Ellevest Inc's ten largest holdings make up 68% of its $684M portfolio in Q4 2020.
  • Ellevest Inc opened 246 new positions and closed 183 in Q4 2020.
  • Ellevest Inc's portfolio value rose 23% quarter-over-quarter to $684M.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.